Sign in
ZURA Stock Price, Chart, Stats & News
Zura Bio Limited
Save
240.58M
Market cap
–
Current P/E
–
Forward P/E
ZURA chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | -44.72% |
ROA | -87.19% |
ROE | -83.86% |
D/E | – |
Interest coverage ratio | – |
ZURA valuation
P/E | – |
P/S | – |
P/B | 5.50x |
P/CF | -8.61x |
P/FCF | -5.94x |
P/OCF | -8.61x |
PEG | 0.11x |
EV multiple | -6.71x |
About
Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.
Similar securities
Based on sector and market capitalization
Report issue